Cargando…
Ligand-induced conformational selection predicts the selectivity of cysteine protease inhibitors
Cruzain, a cysteine protease of Trypanosoma cruzi, is a validated target for the treatment of Chagas disease. Due to its high similarity in three-dimensional structure with human cathepsins and their sequence identity above 70% in the active site regions, identifying potent but selective cruzain inh...
Autores principales: | Sartori, Geraldo Rodrigues, Leitão, Andrei, Montanari, Carlos A., Laughton, Charles A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922342/ https://www.ncbi.nlm.nih.gov/pubmed/31856175 http://dx.doi.org/10.1371/journal.pone.0222055 |
Ejemplares similares
-
Apoferritin encapsulation of cysteine protease inhibitors for cathepsin L inhibition in cancer cells
por: Quilles Junior, José C., et al.
Publicado: (2019) -
Anti-trypanosomal activity of non-peptidic nitrile-based cysteine protease inhibitors
por: Burtoloso, Antonio C. B., et al.
Publicado: (2017) -
Targeting the nsp2 Cysteine Protease of Chikungunya Virus Using FDA Approved Library and Selected Cysteine Protease Inhibitors
por: Kumar, Prateek, et al.
Publicado: (2019) -
Mapping the S1 and S1’ subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents
por: Cianni, Lorenzo, et al.
Publicado: (2020) -
Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
por: Park, Ji-Young, et al.
Publicado: (2012)